NW
DXCM icon

NewEdge Wealth’s DexCom DXCM Stock Holding History

NewEdge Wealth’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$337K Buy
5,000
+66
+1% +$4.4K ﹤0.01% 1000
2026
Q1 		$310K Buy
+4,934
New +$344K ﹤0.01% 956
2025
Q4 		– Sell
-3,853
Closed -$228K – 1194
2025
Q3 		$228K Sell
3,853
-11,604
-75% -$918K ﹤0.01% 952
2025
Q2 		$1.18M Buy
15,457
+5,880
+61% +$461K 0.02% 493
2025
Q1 		$654K Buy
9,577
+4,467
+87% +$365K 0.01% 565
2024
Q4 		$397K Sell
5,110
-3,031
-37% -$224K 0.01% 691
2024
Q3 		$546K Sell
8,141
-26,857
-77% -$2.21M 0.01% 601
2024
Q2 		$3.97M Sell
34,998
-121
-0.3% -$15.3K 0.09% 200
2024
Q1 		$4.45M Sell
35,119
-2,793
-7% -$351K 0.1% 181
2023
Q4 		$4.7M Buy
37,912
+30,440
+407% +$3.11M 0.12% 148
2023
Q3 		$697K Buy
7,472
+3,323
+80% +$375K 0.02% 414
2023
Q2 		$533K Sell
4,149
-4
-0.1% -$484 0.02% 452
2023
Q1 		$482K Buy
4,153
+131
+3% +$14.7K 0.02% 412
2022
Q4 		$455K Buy
4,022
+33
+0.8% +$3.62K 0.02% 380
2022
Q3 		$321K Sell
3,989
-9,391
-70% -$795K 0.02% 414
2022
Q2 		$997K Buy
13,380
+3,384
+34% +$309K 0.05% 285
2022
Q1 		$1.28M Buy
9,996
+412
+4% +$45.1K 0.06% 198
2021
Q4 		$1.29M Buy
9,584
+1,668
+21% +$240K 0.05% 210
2021
Q3 		$1.08M Buy
7,916
+3,644
+85% +$460K 0.06% 175
2021
Q2 		$456K Hold
4,272
– – 0.03% 219
2021
Q1 		$384K Buy
+4,272
New +$401K 0.04% 239

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

NewEdge Wealth's DXCM Position: Q2 2026 in Review

NewEdge Wealth increased its DexCom (DXCM) stake by 1.3% in Q2 2026, buying an estimated $4.4K and bringing the position to 5,000 shares worth $337K. The position accounts for ﹤0.01% of the portfolio, ranked #1000.

NewEdge Wealth first reported a position in DXCM in Q1 2021 and has held it in 21 quarters since. The position peaked at $4.7M in Q4 2023. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • NewEdge Wealth held 5,000 shares of DexCom worth $337K as of Q2 2026.
  • NewEdge Wealth bought 66 DexCom shares in Q2 2026, an estimated $4.4K.
  • DexCom made up ﹤0.01% of NewEdge Wealth's portfolio in Q2 2026, its #1000 holding.
  • NewEdge Wealth first reported a position in DexCom in Q1 2021 and has held it in 21 quarters since.
  • NewEdge Wealth's DexCom position peaked at $4.7M in Q4 2023.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on NewEdge Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.